We still do not have an agreement with LiveWire.
The contemplated sale and license would be exclusive to LiveWire with respect to manufacturing and distribution through the regional reps like Adia Asia as well as to all retail points of sale. When we sell the product ourselves the orders would be fulfilled in the same way, as though we are just another retailer or wholesale distributor partner of LiveWire.
If an agreement is reached and an exclusive license is granted, we would need to defer to LiveWire's business process for disclosing sales estimates and sales numbers.
At this moment it is impossible to provide an update beyond the obvious: the existing inventory is selling and the proceeds are being deposited to our bank account. It is not yet clear what the scale of those sales are. Some of the inventory has expired by now and will become promotional material and display props for our future marketing campaigns but will not be sold. It is not yet clear how much inventory has expired, nor how much inventory is still on-hand and still present on store shelves in our distribution channels.
The co-founders of the Adia probiotics business have been deciding what they want to do next, and everyone is exploring options. Any outcome, and any growth strategy from this point forward, that honors the rights of all stakeholders and produces new opportunity to expand the customer base in economic time at a steady pace will be a good outcome here. The most important next step is to finish raising additional capital, and that does not hinge on the status of the probiotics inventory nor the current/historical pace of probiotics sales.
